US 10906914
Furoquinolinediones as inhibitors of TDP2
granted A61KA61K31/122A61K31/136
Quick answer
US patent 10906914 (Furoquinolinediones as inhibitors of TDP2) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/122, A61K31/136, A61K31/194, A61K31/343